Company Filing History:
Years Active: 2013
Title: **Inventor Ryoko Wada: A Pioneer in Antitussive Pharmaceutical Innovations**
Introduction
Ryoko Wada, an inventive mind from Kumamoto, Japan, has made significant strides in the field of pharmaceutical science. With a unique focus on cough suppression, Wada has been instrumental in developing an innovative solution that addresses a common health issue.
Latest Patents
Wada holds a patent for a pharmaceutical composition designed for the prevention, treatment, and symptom amelioration of cough. This composition features activated Factor XI, a polypeptide chain that serves as an effective antitussive for chronic cough triggered by stimuli at the tracheal bifurcation. The patent highlights a formulation comprising a full-length amino acid sequence constituting activated Factor XI, with the potential for alterations through deletions, substitutions, or additions to the amino acid sequence. This innovative approach presents a promising avenue for providing relief to individuals suffering from persistent coughs.
Career Highlights
Throughout his career, Ryoko Wada has contributed to prominent research institutions, including the Chemo-Sero-Therapeutic Research Institute and Ginkyo Academy Kumamoto Health Science University. His tenure at these organizations has been marked by dedication to advancing therapeutic solutions and improving patient care in the realm of respiratory health.
Collaborations
Wada's journey has been enriched by collaborations with talented colleagues such as Shintaro Kamei and Asami Shindome. Working alongside these professionals, Wada has been able to enhance the innovative potential of his research, leading to the development of novel therapeutic agents in the pharmaceutical sector.
Conclusion
Ryoko Wada's contributions to the pharmaceutical industry underscore the importance of innovation in addressing health challenges. His patent on activated Factor XI exemplifies a commitment to improving patient outcomes, marking him as a noteworthy inventor in the field of cough suppression therapies. Through continuous research and collaboration, Wada is poised to further impact the future of medical science positively.